# Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

> clinical trial · VERIFIED · 2026-08-05

Status: COMPLETED · Sponsor: Sanofi Pasteur, a Sanofi Company · Condition: Respiratory Syncytial Virus Immunization

- Company: Sanofi Pasteur, a Sanofi Company
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT05639894

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.